Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:02 pm Unchanged | 2025-12-31 | 13G | APREA THERAPEUTICS INC APRE | Nantahala Capital Management LLC | 411,520 4.500% | 0 (Unchanged) | Filing History |
| 2026-02-13 5:01 pm Purchase | 2025-12-31 | 13G | ANTERIS TECHNOLOGIES GLOBAL CO AVR | Nantahala Capital Management LLC | 3,143,154 7.520% | 1,224,488![]() (+63.82%) | Filing History |
| 2026-02-13 5:00 pm Unchanged | 2025-12-31 | 13G | ANEBULO PHARMACEUTICALS INC CO ANEB | Nantahala Capital Management LLC | 3,547,398 8.530% | 0 (Unchanged) | Filing History |
| 2026-02-13 5:00 pm Purchase | 2025-12-31 | 13G | APYX MED CORP COM APYX | Nantahala Capital Management LLC | 4,112,705 9.990% | 619,470![]() (+17.73%) | Filing History |
| 2026-02-13 5:00 pm Purchase | 2025-12-31 | 13G | GRACE THERAPEUTICS, INC GRCE | Nantahala Capital Management LLC | 1,586,659 9.990% | 182,627![]() (+13.01%) | Filing History |
| 2025-12-19 4:15 pm Sale | 2025-12-17 | 13D | EVOKE PHARMA INC PAR $0.00 EVOK | Nantahala Capital Management LLC | 0 0.000% | -268,431![]() (Position Closed) | Filing History |
| 2025-11-14 4:54 pm Purchase | 2025-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Nantahala Capital Management LLC | 1,235,000 9.390% | 335,000![]() (+37.22%) | Filing History |
| 2025-11-14 4:47 pm Purchase | 2025-09-30 | 13G | INSPIREMD INC NSPR | Nantahala Capital Management LLC | 4,255,729 9.990% | 1,217,794![]() (+40.09%) | Filing History |
| 2025-11-14 4:44 pm Purchase | 2025-09-30 | 13G | FRACTYL HEALTH INC GUTS | Nantahala Capital Management LLC | 13,283,628 9.990% | 13,283,628![]() (New Position) | Filing History |
| 2025-11-14 4:44 pm Purchase | 2025-09-30 | 13G | ESTABLISHMENT LABS HLDGS INC C ESTA | Nantahala Capital Management LLC | 1,973,492 6.910% | 290,804![]() (+17.28%) | Filing History |
| 2025-11-14 4:43 pm Purchase | 2025-09-30 | 13G | EVOLUS INC EOLS | Nantahala Capital Management LLC | 5,726,857 8.850% | 1,975,514![]() (+52.66%) | Filing History |
| 2025-11-14 4:41 pm Purchase | 2025-09-30 | 13G | EVENTBRITE INC EB | Nantahala Capital Management LLC | 6,831,395 8.450% | 900,448![]() (+15.18%) | Filing History |
| 2025-11-14 4:40 pm Purchase | 2025-09-30 | 13G | EHEALTH, INC. EHTH | Nantahala Capital Management LLC | 1,761,441 5.760% | 450,000![]() (+34.31%) | Filing History |
| 2025-11-14 4:40 pm Sale | 2025-09-30 | 13G | ENVVENO MED CORP COM NVNO | Nantahala Capital Management LLC | 19,684 3.460% | -17,055![]() (-46.42%) | Filing History |
| 2025-11-14 4:40 pm Purchase | 2025-09-30 | 13G | DARIOHEALTH CORP COM PAR 0.000 DRIO | Nantahala Capital Management LLC | 568,844 9.990% | 334,343![]() (+142.58%) | Filing History |
| 2025-11-14 4:39 pm Purchase | 2025-09-30 | 13G | X4 PHARMACEUTICALS INC XFOR | Nantahala Capital Management LLC | 2,244,319 9.990% | 2,244,319![]() (New Position) | Filing History |
| 2025-11-14 4:39 pm Sale | 2025-09-30 | 13G | VERASTEM INC VSTM | Nantahala Capital Management LLC | 4,626,236 7.130% | -833,042![]() (-15.26%) | Filing History |
| 2025-11-14 4:38 pm Purchase | 2025-09-30 | 13G | DESTINATION XL GROUP INC DXLG | Nantahala Capital Management LLC | 4,505,000 8.360% | 4,505,000![]() (New Position) | Filing History |
| 2025-11-14 4:37 pm Sale | 2025-09-30 | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Nantahala Capital Management LLC | 3,484,315 3.570% | -2,450,000![]() (-41.29%) | Filing History |
| 2025-11-14 4:37 pm Purchase | 2025-09-30 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Nantahala Capital Management LLC | 3,185,564 9.990% | 351,228![]() (+12.39%) | Filing History |

